NUMBER OF SHARES IN ELEKTA AS OF FEBRUARY 29, 2008

NUMBER OF SHARES IN ELEKTA AS OF FEBRUARY 29, 2008

PRESS RELEASE			
Stockholm, Sweden, February 29, 2008

According to legislation, all publicly listed companies must - if the number of
shares has changed during the month - publish the total number of shares in the
company on the last trading day of the month.

During February, 1,200 new B shares were issued in Elekta through the exercise
of warrants distributed within the framework of the established option program. 

The total number of shares in Elekta as of February 29, 2008, amounts to
93,904,516 divided between 3,562,500 A shares and 90,342,016 B shares.

One Series A share entitles the holder to 10 votes and one Series B share to one
vote.

Elekta's current holding of own shares (treasury stock) amounts to 2,582,171 B
shares. The Annual General Meeting on September 25, 2007, resolved to cancel
1,630,871 of these shares (the total number of treasury stock at that time) and
the cancellation process is ongoing. The Board intends to propose to the next
AGM that also the 951,300 shares repurchased during January and February 2008,
should be cancelled.





******

For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com  


About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 4,500 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.